. Author manuscript; available in PMC: 2022 Sep 1.

Published in final edited form as: Clin Pharmacol Ther. 2021 Jul 23;110(3):733–740. doi: 10.1002/cpt.2337

Table 2.

Association between rs4149056 genotype and statin-induced myopathy + rhabdomyolysis by statin group

Statin-type	Genotype	TT	TC	CC	MAF	χ² p-value^a
All Statins	Cases	153	64	16	0.21
	Controls	1722	569	51	0.14	1.80E-06
Simvastatin	Cases	47	29	6	0.25
	Controls	537	195	16	0.15	4.55E-04
Lovastatin	Cases	59	19	7	0.19
	Controls	671	210	20	0.14	8.32E-04
Atorvastatin	Cases	47	16	3	0.17
	Controls	514	164	15	0.14	0.40

MAF, minor allele frequency

Differences in minor allele frequency between cases and controls for each statin group.